Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Adam E. Haynes, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Julie A. Panepinto, Marcelo C. Pasquini, Anita Rajasekhar, Ravi Sarode, William A. Wood

Blood (2014) 124 (24): 3524–3528.

https://doi.org/10.1182/blood-2014-09-599399

Published: 2014

Includes: Supplemental data

Journal Articles

The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Marcelo Pasquini, Ravindra Sarode, Lawrence Solberg, Jr, Adam E. Haynes, Mark A. Crowther

Blood (2013) 122 (24): 3879–3883.

https://doi.org/10.1182/blood-2013-07-518423

Published: 2013

Includes: Supplemental data

Journal Articles

Clinical Outcomes For Patients With Sickle Cell Disease: 24-Month Follow-Up In An Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Matthew M Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD, PhD, Carole Paley, MD, Jason Esposito MSHS, McNamara Katie MSHS CCRA, Elliott Vichinsky, MD

Blood (2013) 122 (21): 988.

https://doi.org/10.1182/blood.V122.21.988.988

Published: 2013

Journal Articles

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Matthew M. Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD, PhD, Carole Paley, MD, Jason Esposito, MSHS, Elliott P. Vichinsky, MD

Blood (2012) 120 (21): 1010.

https://doi.org/10.1182/blood.V120.21.1010.1010

Published: 2012

Journal Articles

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Janet L. Kwiatkowski, Hae-Young Kim, Alexis A. Thompson, Charles T. Quinn, Brigitta U. Mueller, Isaac Odame, Patricia J. Giardina, Elliott P. Vichinsky, Jeanne M. Boudreaux, Alan R. Cohen, John B. Porter, Thomas Coates, Nancy F. Olivieri, Ellis J. Neufeld, for the Thalassemia Clinical Research Network

Blood (2012) 119 (12): 2746–2753.

https://doi.org/10.1182/blood-2011-04-344507

Published: 2012

Includes: Supplemental data

Journal Articles

Baseline Characteristics of Patients with Sickle Cell Disease in An Ongoing 5-Year, Prospective, Noninterventional Registry Trial

Matthew M. Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, Carole Paley, Jason Esposito, Surabhi Sharma, Elliott Vichinsky, MD

Blood (2011) 118 (21): 1060.

https://doi.org/10.1182/blood.V118.21.1060.1060

Published: 2011

Journal Articles

Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.

Janet L Kwiatkowski, MD, MSCE, Hae-Young Kim, MS, DrPh, Alexis A. Thompson, Charles T. Quinn, MD, MS, Brigitta U Mueller, Isaac Odame, MBChB, Patricia J Giardina, MD, Elliott P Vichinsky, MD, Jeanne Boudreaux, MD, John B Porter, Thomas Coates, Nancy F Olivieri, MD, Ellis J Neufeld, MD, PhD

Blood (2009) 114 (22): 4056.

https://doi.org/10.1182/blood.V114.22.4056.4056

Published: 2009

Journal Articles

Hemoglobin H-Constant Spring in North America: A Common Alpha Thalassemia with Frequent Complications.

Titi Singer, Hae-Young Kim, Nancy F Olivieri, Janet Kwiatkowski, Ashutosh Lal, Thomas D. Coates, Susan Carson, Melody J. Cunningham, Patricia J Giardina, Brigitta U Mueller, Charles Quinn, Elliott Vichinsky, Thalassemia Clinical Research Network

Blood (2008) 112 (11): 1880.

https://doi.org/10.1182/blood.V112.11.1880.1880

Published: 2008

Journal Articles

Day Hospital Approach to Uncomplicated Vaso-Occlusive Crises in Children with Sickle Cell Disease.

Jean L. Raphael, MD, MPH, Aditi Kamdar, Brigitta U. Mueller, MD

Blood (2007) 110 (11): 5172.

https://doi.org/10.1182/blood.V110.11.5172.5172

Published: 2007

Journal Articles

Long-Term Efficacy and Safety of Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, in Patients with Sickle Cell Disease (SCD).

Elliott Vichinsky, Thomas D. Coates, Alexis A. Thompson, Brigitta U. Mueller, Darlene Lagrone, Matthew M. Heeney

Blood (2007) 110 (11): 3395.

https://doi.org/10.1182/blood.V110.11.3395.3395

Published: 2007

Journal Articles

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

Carolyn M. Bennett, Zora R. Rogers, Daniel D. Kinnamon, James B. Bussel, Donald H. Mahoney, Thomas C. Abshire, Hadi Sawaf, Theodore B. Moore, Mignon L. Loh, Bertil E. Glader, Maggie C. McCarthy, Brigitta U. Mueller, Thomas A. Olson, Adonis N. Lorenzana, William C. Mentzer, George R. Buchanan, Henry A. Feldman, Ellis J. Neufeld, the Pediatric Rituximab/ITP Study Group and the Glaser Pediatric Research Network

Blood (2006) 107 (7): 2639–2642.

https://doi.org/10.1182/blood-2005-08-3518

Published: 2006

Includes: Supplemental data

Journal Articles

Phamacokinetics (PK) Substudy of Rituximab in a Prospective Clinical Trial for Pediatric Chronic Immune Thrombocytopenic Purpura (cITP).

Carolyn M. Bennett, James B. Bussel, Brigitta U. Mueller, Thomas C. Abshire, Hadi Sawaf, Theodore B. Moore, Mignon L. Loh, Zora R. Rogers, Henry A. Feldman, Ellis J. Neufeld, The Glaser Pediatric Research Network for the Pediatric ITP/Rituximab Study Group

Blood (2005) 106 (11): 1243.

https://doi.org/10.1182/blood.V106.11.1243.1243

Published: 2005

NARROW

Five hematologic tests and treatments to question

The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question

Clinical Outcomes For Patients With Sickle Cell Disease: 24-Month Follow-Up In An Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Baseline Characteristics of Patients with Sickle Cell Disease in An Ongoing 5-Year, Prospective, Noninterventional Registry Trial

Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.

Hemoglobin H-Constant Spring in North America: A Common Alpha Thalassemia with Frequent Complications.

Day Hospital Approach to Uncomplicated Vaso-Occlusive Crises in Children with Sickle Cell Disease.

Long-Term Efficacy and Safety of Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, in Patients with Sickle Cell Disease (SCD).

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

Phamacokinetics (PK) Substudy of Rituximab in a Prospective Clinical Trial for Pediatric Chronic Immune Thrombocytopenic Purpura (cITP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only